NO984143L - Ny prosess for å fremstille overflatemodifiserende stoffer - Google Patents

Ny prosess for å fremstille overflatemodifiserende stoffer

Info

Publication number
NO984143L
NO984143L NO984143A NO984143A NO984143L NO 984143 L NO984143 L NO 984143L NO 984143 A NO984143 A NO 984143A NO 984143 A NO984143 A NO 984143A NO 984143 L NO984143 L NO 984143L
Authority
NO
Norway
Prior art keywords
new process
surface modifying
producing surface
modifying substances
heparin
Prior art date
Application number
NO984143A
Other languages
English (en)
Norwegian (no)
Other versions
NO984143D0 (no
Inventor
Elisabeth Scholander
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Priority to NO984143A priority Critical patent/NO984143L/no
Publication of NO984143D0 publication Critical patent/NO984143D0/no
Priority to DE69909104T priority patent/DE69909104T2/de
Priority to PT99944936T priority patent/PT1112097E/pt
Priority to AU57652/99A priority patent/AU757913B2/en
Priority to CA002342991A priority patent/CA2342991C/en
Priority to AT99944936T priority patent/ATE243538T1/de
Priority to PCT/NO1999/000277 priority patent/WO2000013718A1/en
Priority to BRPI9913516-7A priority patent/BR9913516B1/pt
Priority to EP99944936A priority patent/EP1112097B1/en
Priority to ES99944936T priority patent/ES2203177T3/es
Priority to US09/763,873 priority patent/US6461665B1/en
Priority to JP2000568523A priority patent/JP4152075B2/ja
Priority to KR1020017002986A priority patent/KR100669132B1/ko
Priority to DK99944936T priority patent/DK1112097T3/da
Publication of NO984143L publication Critical patent/NO984143L/no
Priority to NO20011182A priority patent/NO321029B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO984143A 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer NO984143L (no)

Priority Applications (15)

Application Number Priority Date Filing Date Title
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer
DK99944936T DK1112097T3 (da) 1998-09-09 1999-09-08 Ny fremgangsmåde til fremstilling af substanser til overflademodificering
PCT/NO1999/000277 WO2000013718A1 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
EP99944936A EP1112097B1 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
AU57652/99A AU757913B2 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
CA002342991A CA2342991C (en) 1998-09-09 1999-09-08 Antithrombogenic surfaces comprising immobilized heparin and methods for producing same
AT99944936T ATE243538T1 (de) 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung
DE69909104T DE69909104T2 (de) 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung
BRPI9913516-7A BR9913516B1 (pt) 1998-09-09 1999-09-08 processo para a produção de uma modificação em superfìcie que tem uma atividade não trombogênica melhorada.
PT99944936T PT1112097E (pt) 1998-09-09 1999-09-08 Processo novo para preparar substancias de modificacao de superficies
ES99944936T ES2203177T3 (es) 1998-09-09 1999-09-08 Nuevo procedimiento para preparar sustancias de modificacion de superficies.
US09/763,873 US6461665B1 (en) 1998-09-09 1999-09-08 Process for preparing surface modification substances
JP2000568523A JP4152075B2 (ja) 1998-09-09 1999-09-08 表面改質物質を調整する新方法
KR1020017002986A KR100669132B1 (ko) 1998-09-09 1999-09-08 표면 개질을 생성하는 신규 방법
NO20011182A NO321029B1 (no) 1998-09-09 2001-03-08 Ny fremgangsmate for a fremskaffe overflatemodifikasjon samt overflatemodifisert substrat.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer

Publications (2)

Publication Number Publication Date
NO984143D0 NO984143D0 (no) 1998-09-09
NO984143L true NO984143L (no) 2000-03-10

Family

ID=19902393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer

Country Status (14)

Country Link
US (1) US6461665B1 (es)
EP (1) EP1112097B1 (es)
JP (1) JP4152075B2 (es)
KR (1) KR100669132B1 (es)
AT (1) ATE243538T1 (es)
AU (1) AU757913B2 (es)
BR (1) BR9913516B1 (es)
CA (1) CA2342991C (es)
DE (1) DE69909104T2 (es)
DK (1) DK1112097T3 (es)
ES (1) ES2203177T3 (es)
NO (1) NO984143L (es)
PT (1) PT1112097E (es)
WO (1) WO2000013718A1 (es)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
SE515295C2 (sv) 1999-11-23 2001-07-09 Medicarb Ab Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat
IE20030353A1 (en) * 2002-05-10 2003-11-26 Salviac Ltd An embolic protection system
US6926965B2 (en) * 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
US20050281857A1 (en) * 2004-05-25 2005-12-22 Heyer Toni M Methods and reagents for preparing biomolecule-containing coatings
US20060159650A1 (en) * 2005-01-14 2006-07-20 Bacterin, Inc. Composition and method for covalently coupling an antithrombotic substance and a hydrophilic polymer
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
MX2008007716A (es) 2005-12-13 2008-09-26 Exthera Ab Metodo para eliminar extra corporalmente de la sangre un microbio patogeno, una celula inflamatoria o una proteina inflamatoria.
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
US8496953B2 (en) * 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US8986713B2 (en) * 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US9114194B2 (en) * 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
WO2008032758A1 (en) 2006-09-15 2008-03-20 Toray Industries, Inc. Substrate and method for production thereof
US20080200421A1 (en) 2007-02-21 2008-08-21 Zhao Jonathon Z Coating for a medical device having an anti-thrombotic conjugate
US20090281059A1 (en) * 2007-02-21 2009-11-12 Robert Falotico Coating for a medical device having an anti-thrombotic conjugate
US9693841B2 (en) 2007-04-02 2017-07-04 Ension, Inc. Surface treated staples, sutures and dental floss and methods of manufacturing the same
US8114465B2 (en) * 2007-04-02 2012-02-14 Ension, Inc. Process for preparing a substrate coated with a biomolecule
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8383156B2 (en) 2007-04-30 2013-02-26 Cordis Corporation Coating for a medical device having an anti-thrombotic conjugate
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
AU2008265838A1 (en) * 2007-06-18 2008-12-24 Exthera Medical Llc Device and method for restoration of the condition of blood
US20090018646A1 (en) * 2007-07-10 2009-01-15 Zhao Jonathon Z Coating Employing an Anti-Thrombotic Conjugate
US20090192079A1 (en) * 2007-10-09 2009-07-30 Genzyme Corporation Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
BR112012021347A2 (pt) 2008-02-26 2019-09-24 Jenavalve Tecnology Inc stent para posicionamento e ancoragem de uma prótese valvular em um local de implantação no coração de um paciente
GB0816783D0 (en) * 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
US7819914B2 (en) * 2008-12-16 2010-10-26 Cordis Corporation Adhesion promoting primer for coated surfaces
US20100161039A1 (en) * 2008-12-23 2010-06-24 Vipul Dave Adhesion promoting temporary mask for coated surfaces
EP2213264A1 (en) 2009-01-30 2010-08-04 Cordis Corporation Reservoir eluting stent
AU2010215936B2 (en) * 2009-02-21 2015-03-05 Covidien Lp Medical devices having activated surfaces
CA2738676A1 (en) * 2009-02-21 2010-08-26 Sofradim Production Medical device with degradation-retarding coating
US8658707B2 (en) 2009-03-24 2014-02-25 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expanded functional products obtained therefrom and reaction of the expanded products
US9139669B2 (en) 2009-03-24 2015-09-22 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expandable functional products obtained therefrom and reaction of the expanded products
US8591932B2 (en) * 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
JP5925693B2 (ja) 2009-12-01 2016-05-25 エクステラ・メディカル・コーポレーション 表面固定した多糖類を用いた、血液からのサイトカイン除去法
US20120271010A1 (en) 2009-12-24 2012-10-25 Toray Industries, Inc. Hydrophilic polymer compound having anticoagulation effect
GB201004101D0 (en) 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities
US9744031B2 (en) 2010-05-25 2017-08-29 Jenavalve Technology, Inc. Prosthetic heart valve and endoprosthesis comprising a prosthetic heart valve and a stent
US9839540B2 (en) 2011-01-14 2017-12-12 W. L. Gore & Associates, Inc. Stent
US10166128B2 (en) 2011-01-14 2019-01-01 W. L. Gore & Associates. Inc. Lattice
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US9415193B2 (en) 2011-03-04 2016-08-16 W. L. Gore & Associates, Inc. Eluting medical devices
US20120310210A1 (en) 2011-03-04 2012-12-06 Campbell Carey V Eluting medical devices
RU2625756C2 (ru) 2011-03-11 2017-07-18 В.Л. Гор Энд Ассошиейтс, Инк. Усовершенствованные иммобилизованные биологические объекты
TW201311774A (zh) 2011-06-23 2013-03-16 Toray Industries 具有抗血液凝固作用的疏水性高分子化合物
TW201309354A (zh) 2011-06-23 2013-03-01 Toray Industries 醫療材料
US9775933B2 (en) 2012-03-02 2017-10-03 W. L. Gore & Associates, Inc. Biocompatible surfaces and devices incorporating such surfaces
WO2013188073A1 (en) 2012-06-13 2013-12-19 Exthera Medical, Llc Use of heparin and carbohydrates to treat cancer
US9283072B2 (en) 2012-07-25 2016-03-15 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
US9931193B2 (en) 2012-11-13 2018-04-03 W. L. Gore & Associates, Inc. Elastic stent graft
US9968443B2 (en) 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US9101469B2 (en) 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
US9144492B2 (en) 2012-12-19 2015-09-29 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves, preformed valve
AU2014302884B2 (en) 2013-06-24 2018-03-29 Exthera Medical Corporation Blood filtration system containing mannose coated substrate
JP6563394B2 (ja) 2013-08-30 2019-08-21 イェーナヴァルヴ テクノロジー インコーポレイテッド 人工弁のための径方向に折り畳み自在のフレーム及び当該フレームを製造するための方法
CA2928866C (en) 2013-11-08 2021-11-09 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
WO2015080177A1 (ja) 2013-11-28 2015-06-04 東レ株式会社 抗血栓性材料
WO2015080176A1 (ja) 2013-11-28 2015-06-04 東レ株式会社 抗血栓性材料
US10842918B2 (en) 2013-12-05 2020-11-24 W.L. Gore & Associates, Inc. Length extensible implantable device and methods for making such devices
WO2015122429A1 (ja) 2014-02-12 2015-08-20 東レ株式会社 人工血管
US11839698B2 (en) 2014-03-13 2023-12-12 W. L. Gore & Associates, Inc. Drug composition and coating
JP2017513636A (ja) 2014-04-24 2017-06-01 エクスセラ メディカル コーポレイション 高流量を用いて血液から細菌を除去するための方法
US9827094B2 (en) 2014-09-15 2017-11-28 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
EP3197342B1 (en) 2014-09-22 2020-08-05 ExThera Medical Corporation Wearable hemoperfusion device
CN107530168B (zh) 2015-05-01 2020-06-09 耶拿阀门科技股份有限公司 在心脏瓣膜替换中具有降低的起搏器比例的装置和方法
EP3095509A1 (en) 2015-05-18 2016-11-23 Defymed Membranes functionalized with heparin for bioartificial organs
US10561766B2 (en) 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating
EP3422943A4 (en) 2016-03-02 2019-10-16 ExThera Medical Corporation METHOD OF TREATING DRUG ENTRIES
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
JP7248430B2 (ja) 2016-04-21 2023-03-29 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 直径を調節可能な内部人工器官ならびに関連したシステムおよび方法
EP3454795B1 (en) 2016-05-13 2023-01-11 JenaValve Technology, Inc. Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system
EP3521328B1 (en) 2016-09-30 2021-03-10 Toray Industries, Inc. Copolymer and medical material using same
BR112019006967A2 (pt) 2016-10-07 2019-07-02 Toray Industries pano tecido tubular
EP3318294A1 (en) 2016-11-08 2018-05-09 Defymed Kit for in situ delivery of a compound of interest
EP3573579B1 (en) 2017-01-27 2023-12-20 JenaValve Technology, Inc. Heart valve mimicry
CN110461274B (zh) 2017-03-31 2022-09-02 东丽株式会社 筒状结构体
WO2019067220A1 (en) 2017-09-27 2019-04-04 W. L. Gore & Associates, Inc. PROSTHETIC VALVES WITH MECHANICALLY COUPLED VALVULAR BLADES
CN115177403A (zh) 2017-09-27 2022-10-14 W.L.戈尔及同仁股份有限公司 带有可扩张框架的假体瓣膜以及相关系统和方法
US11439502B2 (en) 2017-10-31 2022-09-13 W. L. Gore & Associates, Inc. Medical valve and leaflet promoting tissue ingrowth
AU2019214612A1 (en) 2018-01-30 2020-07-09 Toray Industries, Inc. Plain-weave fabric, method for manufacturing same, and stent graft
CA3093027A1 (en) 2018-03-09 2019-09-12 Carmeda Ab Improvements to processes for immobilising biological entities
US20190275213A1 (en) 2018-03-09 2019-09-12 Carmeda Ab Immobilising biological entities
EP3860670A1 (en) 2018-10-03 2021-08-11 Carmeda AB Immobilised biological entities
US20200179663A1 (en) 2018-12-11 2020-06-11 W. L. Gore & Associates, Inc. Medical devices for shunts, occluders, fenestrations and related systems and methods
CA3123620A1 (en) 2018-12-21 2020-06-25 W. L. Gore & Associates, Inc. Implantable medical device with adjustable blood flow
EP3919664A4 (en) 2019-01-30 2022-10-19 Toray Industries, Inc. MEDICAL BASE MATERIAL FOR CARDIOVASCULAR IN-DENTATION DEVICE
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
AU2020381577B2 (en) 2019-11-15 2023-11-16 W. L. Gore & Associates, Inc. Left atrial appendage device and methods
EP4100104A1 (en) 2020-02-04 2022-12-14 W.L. Gore & Associates, Inc. Inflow / outflow cannula
EP3892259A1 (en) 2020-04-09 2021-10-13 Defymed Membranes for medical devices
CN115697300A (zh) 2020-04-09 2023-02-03 帝梵麦德公司 用于医疗装置的膜

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4600652A (en) 1985-04-01 1986-07-15 Warner-Lambert Company Permanently bonded antithrombogenic polyurethane surface
US5049403A (en) * 1989-10-12 1991-09-17 Horsk Hydro A.S. Process for the preparation of surface modified solid substrates
IT1260136B (it) 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
US5679659A (en) 1995-08-22 1997-10-21 Medtronic, Inc. Method for making heparinized biomaterials
US6174326B1 (en) * 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production

Also Published As

Publication number Publication date
PT1112097E (pt) 2003-11-28
JP4152075B2 (ja) 2008-09-17
KR100669132B1 (ko) 2007-01-17
EP1112097A1 (en) 2001-07-04
JP2003507082A (ja) 2003-02-25
CA2342991A1 (en) 2000-03-16
DK1112097T3 (da) 2003-10-20
EP1112097B1 (en) 2003-06-25
US6461665B1 (en) 2002-10-08
BR9913516B1 (pt) 2010-09-21
KR20010088799A (ko) 2001-09-28
ES2203177T3 (es) 2004-04-01
WO2000013718A1 (en) 2000-03-16
DE69909104T2 (de) 2004-04-08
AU5765299A (en) 2000-03-27
CA2342991C (en) 2009-01-27
DE69909104D1 (de) 2003-07-31
ATE243538T1 (de) 2003-07-15
BR9913516A (pt) 2001-06-05
NO984143D0 (no) 1998-09-09
AU757913B2 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
NO984143L (no) Ny prosess for å fremstille overflatemodifiserende stoffer
DE69806498D1 (de) Behandlung von kontaktlinsen mit wässrigen, alkalicarbonat-haltigen lösungen
NO872602D0 (no) Elektrisk kontaktsett, saerlig for bruk under vann.
ES536909A0 (es) Procedimiento para la preparacion de compuestos complejos de piroxicam con ciclodestrinas
DE68902916D1 (de) Herstellung von quecksilberfreiem synthesegas, reduktionsgas oder brenngas.
DE69704433D1 (de) Herstellung von kohlenwasserstofflöslichen hydrocarbylaluminoxanen
EA200000473A1 (ru) Состав модифицированного крахмала для удаления частиц из водных дисперсий
CA2324887A1 (fr) Composition ophtalmique comprenant un .beta.-bloquant
DE59709869D1 (de) Neue substanzbibliothek und damit hergestellte supramolekulare komplexe
EA199800152A1 (ru) Лечение синдрома дефицита внимания/гиперактивности
FI963749A (fi) Huokoinen metallikomposiittikappale
ES2190991T3 (es) Estabilizacion de plaquetas.
NO20012854L (no) Fremgangsmåte for avvanning av organiske v¶sker
ATE357914T1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
ATE246254T1 (de) Verwendung von oxidationsfördernden chemikalien für die oxidation von einem polymer, das die alkoholkonfiguration eines oxidierbaren galaktosetyps enthält.
WO2001042250A3 (en) Process for production of diphenyl-dialkoxysilane, phenylalkyl-dialkoxysilane, octaphenylcyclotetrasiloxane and sym-tetraalkyltetraphenyl-cyclotetrasiloxane
DE69421195D1 (de) Einstufige herstellung von 4,6 dinitroresorcinol aus resorcinol
IT1216721B (it) Procedimento per la produzione di bricchette di combustibile senza fumo trattate.
DE3886225D1 (de) Pyruvat-Oxidase, ihre Herstellung und Verwendung.
KR910008138A (ko) 효소법에 의한 l-세린의 제조법
HUP9900959A2 (hu) Eljárás 3-metoxi-1-propanol előállítására
DE69729114D1 (de) 1,3-diphenylphosphinopropan-liganden und entsprechende übergangsmetallkomplexe, deren herstellung und verwendung
CA2195498A1 (en) Modification of Starch
GB9818650D0 (en) Therapeutic compounds and methods of making and using the same
ES1035311U (es) Cuerpo de pernio mejorado.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application